1- Stevens, P.E.; Levin, A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of Internal Medicine. 2013, 158, 825-30.
3- Andersson, P.; Rydberg, E.; Willenheimer, R. Primary hyperparathyroidism and heart disease—a review. European Heart Journal. 2004, 25, 1776-1787.
4- Nieves, J.W. Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporosis International. 2013, 24, 771–786.
5- Ahmed, F.; Mohammed, A. Magnesium: The Forgotten Electrolyte - A Review on Hypomagnesemia. Medical Sciences. 2019, 7, 56.
6- Volpe, S. L. Magnesium in disease prevention and overall health. Advances in Nutrition. 2013, 4, 378S-83S.
7- Jahnen-Dechent, W.; Ketteler, M. Magnesium basics. Clinical Kidney Journal. 2012, 5, i3–i14.
8- Blaine, J.; Chonchol, M.; Levi, M. Renal control of calcium, phosphate, and magnesium homeostasis. Clinical Journal of the American Society of Nephrology. 2015, 10, 1257–1272.
9- Žeravica, R.; Ilinčić, B.; Čabarkapa, V.; Radosavkić, I.; Samac, J.; Nikoletić, K.; Stošić, Z. Fractional excretion of magnesium and kidney function parameters in nondiabetic chronic kidney disease. Magnesium Research. 2018, 31, 49-57.
10- Gheissari, A.; Andalib, A.; Labibzadeh, N.; Modarresi, M.; Azhir, A.; Merrikhi, A. Fractional excretion of magnesium (FEMg), a marker for tubular dysfunction in children with clinically recovered ischemic acute tubular necrosis. Saudi Journal of Kidney Diseases and Transplantation. 2011, 22, 476.
11- Williams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Kahan, T. ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal. 2018, 39, 3021-3104.
12- Vendrame, l. S.; Scattolini, M.; Brito, V. P. Hipomagnesemia. In Equilíbrio Ácido-Base e Hidroeletrolítico, 3ª ed.; Lopes, R.D.; Editora Atheneu, São Paulo, Brasil, 2007; Volume 16, pp.171-178, 2009.
13- Levin, A.; Stevens, P. E.; Bilous, R. W.; Coresh, J.; De Francisco, A. L.; De Jong, P. E.; Levey, A. S. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013, 3, 1-150.
14- Levy, A. R.; Perkins, R. M.; Johnston, K. M.; Sullivan, S. D.; Sood, V. C.; Agnese, W.; Schnitzler, M. A. An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease. International Journal of Nephrology and Renovascular Disease. 2014, 7, 271.
15- World Health Organization (WHO). Physical Status: the use and interpretation of anthropometry. Report of a WHO Expert Committee, n. 854. Geneva; 2000.
16- Lipschitz, D. A. (1994). Screening for nutritional status in the elderly. Primary Care. 1994, 21, 55-67.
17- Căpuşă, C.; Chirculescu, B.; Vladu, I.; Viaşu, L.; Lipan, M., Moţa, E.; Mircescu, G. The prevalence of biochemical abnormalities of chronic kidney disease. Mineral and bone disorders in untreated non-dialysis patients–a multicenter study. Acta Endocrinologica. 2016, 12, 282.
18-Anderson, J.L.; Vanwoerkom, R.C.; Horne, B.D.; Bair, T.L.; May, H.T.; Lappé, D.L.; Muhlestein, J. B. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? American Heart Journal. 2011, 162, 331-339.
19- Wang, W. H.; Chen, L. W.; Lee, C. C.; Sun, C. Y.; Shyu, Y. C.; Hsu, H. R.; Wu, I. W. Association between parathyroid hormone, 25 (OH) vitamin D, and chronic kidney disease: a population-based study. BioMed Research International, 2017.
20- Peacock, M. Calcium metabolismin health and disease. Clinical Journal of the American Society of Nephrology. 2010, 5, S23–S30.
21- Schiepatti, A.; Pisoni, R.; Remuzzi, G. Pathophysiology and management of chronic kidney disease. Primer on Kidney Diseases. 4th ed. Philadelphia: Elsevier Saunders; 2005, p.444-454.
22- Bouillon, R.; Van Schoor, N.M.; Gielen, E.; Boonen, S.; Mathieu, C.; Vanderschueren, D.; Lips, P. Optimal vitamin D status: A critical analysis on the basis of evidence-based medicine. The Journal of Clinical Endocrinology & Metabolism. 2013, 98, E1283–E1304.
23- Choi, C. K.; Kweon, S. S.; Lee, Y. H.; Nam, H. S.; Park, K. S.; Ryu, S. Y.; Shin, M. H. Serum level vitamin D and parathyroid hormone, and mortality, with or without chronic kidney disease. Journal of Bone and Mineral Metabolism. 2019, 37, 825-834.
24- Sahota, O.; Mundey, M.K.; San, P.; Godber, I.M.; Lawson, N.; Hosking, D.J. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004, 35, 312–319.
25- Vieth, R.; Yasmin, L.; Paul, G. W. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. Journal of Clinical Endocrinology and Metabolism. 2003, 88, 185–191.
26- Jaqueto, M.; Delfino, V. D. A.; Bortolasci, C. C.; Barbosa, D. S.; Morimoto, H. K.; Frange, R. F. N.; Guimarães, F. B. D. S. Os níveis de PTH estão relacionados com estresse oxidativo e inflamação em pacientes renais crônicos em hemodiálise?. Brazilian Journal of Nephrology. 2016, 38, 288-295.
27- Petchey, W.G.; Johnson, D.W.; Hawley, C.M.; Isbel, N.M.; Predictors of vitamin D status in predialysis chronic kidney disease patients: a cross-sectional analysis in a high ultraviolet climate. Journal of Renal Nutrition. 2012, 22, 400-408.
28- Dai, L. J.; Ritchie, G.; Kerstan, D.; Kang, H. S.; Cole, D. E.; Quamme, G. A. Magnesium transport in the renal distal convoluted tubule. Physiological Reviews. 2001, 81, 51-84.
29- Noiri, C.; Shimizu, T.; Takayanagi, K.; Tayama, Y.; Iwashita, T.; Okazaki, S.; Mitarai, T. Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters. Clinical and Experimental Nephrology. 2015, 19, 1071-8.
30- Felsenfeld, A.J.; Levine, B.S.; Rodriguez, M. Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease. Seminars in Dialysis. 2015, 28, 564-577.
31- Navarro-Gonzales, J.F.; Mora-Fernandez, C.; Garcia-Perez, J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Seminars in Dialysis. 2009, 22, 37–44.
32- Chandran, M.; Wong, J. Secondary and tertiary hyperparathyroidism in chronic kidney disease: An endocrine and renal perspective. Indian Journal of Endocrinology and Metabolism. 2019, 23, 391.
33- Hedgeman, E.; Lipworth, L.; Lowe, K.; Saran, R.; Do, T.; Fryzek, J. International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data. International Journal of Nephrology. 2015.
34- Koc, H.; Hoser, H.; Akdag, Y.; Kendir, C.; Ersoy, F. F. Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study. International Urology and Nephrology. 2019, 51, 1261-1270.
35- Tentori, F.; Wang, M.; Bieber, B. A.; Karaboyas, A.; Li, Y.; Jacobson, S. H.; Port, F. K. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clinical Journal of the American Society of Nephrology. 2015, 10, 98-109.
36- Regidor, D. L.; Kovesdy, C. P.; Mehrotra, R.; Rambod, M.; Jing, J.; McAllister, C. J.; Kalantar-Zadeh, K. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. Journal of the American Society of Nephrology. 2008, 19, 2193-2203.
37- Bover, J.; Ureña, P.; Aguilar, A.; Mazzaferro, S.; Benito, S.; López-Báez, V.; Cozzolino, M. Alkaline phosphatases in the complex chronic kidney disease-mineral and bone disorders. Calcified Tissue International. 2018, 103, 111-124.
38- Behets, J.; Spasovski, G.; Sterling, R.; Goodman, G.; Spiegel, D.M.; De Broe, M.E.; D’haese, P.C. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney International. 2015, 87, 846–8